Inozyme Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 324,367 | 0.505% |
General Public | 3,385,906 | 5.27% |
Hedge Funds | 12,735,670 | 19.8% |
VC/PE Firms | 14,616,204 | 22.8% |
Institutions | 33,178,051 | 51.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,841,045 | US$16.4m | 0% | 2.82% | |||
5,673,629 | US$15.9m | -0.96% | 0.03% | |||
4,494,851 | US$12.6m | 0% | 4.69% | |||
4,280,308 | US$12.0m | 0% | 0.94% | |||
4,134,436 | US$11.6m | 5.04% | 0.19% | |||
3,802,883 | US$10.7m | 2.83% | 0.34% | |||
3,491,236 | US$9.8m | 4.43% | no data | |||
3,259,158 | US$9.2m | -2.73% | 0.14% | |||
2,822,318 | US$7.9m | -1.19% | 1.31% | |||
2,624,338 | US$7.4m | -0.19% | no data | |||
2,478,689 | US$7.0m | 0.05% | no data | |||
2,437,689 | US$6.8m | 0% | 0.3% | |||
1,744,453 | US$4.9m | -2.43% | no data | |||
1,562,500 | US$4.4m | 0% | 0.64% | |||
1,368,810 | US$3.8m | 20% | 1.52% | |||
1,191,140 | US$3.3m | -18.6% | 0.56% | |||
1,171,172 | US$3.3m | 1.69% | no data | |||
1,120,027 | US$3.1m | 0% | 1.2% | |||
1,050,420 | US$3.0m | 5.04% | no data | |||
1,003,124 | US$2.8m | 0.24% | 0.02% | |||
564,549 | US$1.6m | 0% | 0.52% | |||
446,152 | US$1.3m | 17.4% | no data | |||
438,845 | US$1.2m | 6.68% | no data | |||
409,896 | US$1.2m | 23.7% | no data | |||
266,696 | US$749.4k | 0% | no data |